Summary.-The receptor patterns of cell suspensions from 29 cases of non-Hodgkin lymphoma were correlated with the histology of the nodes from which the cells were taken. Twenty-two were judged to be predominantly or largely B-cell, and because of this preponderance these were divided by a method based on the distribution of surface immunoglobulin and the expression of Fc and C3 receptors.
THE first purpose of this paper is to show how receptor studies on human lymphomas may be used to identify the cells present (Table I ; Fig. 1 ). The second is to assess the maturity of the B cell by a number of cell surface markers, and the third is to relate the surface markers to the histology of the tumour. Previous attempts to identify the cells present in human lymphomas by surface marker techniques (Brouet, Labaume and Seligmann, 1975; Cooper et al., 1975; Dorfman, 1975; Gajl-Peezalska, Bloomfield and Sosin, 1975; Habeshaw and Stuart, 1975; Jaffe et al., 1975; Huang et al., 1974; Peter, Mackenzie and Glassy, 1974; Stuart and Habeshaw, 1976; Smith et al., 1973) have all shown that most non-Hodgkin lymphomas consist predominantly of B cells, with a minority of T cells. A few are derived from T cells, and those arising from macrophages are distinctly uncommon. Tumours without B, T or macrophage markers we call "receptorsilent". Some authors have encountered tumours in which the sum of B and T cells appears to exceed the total cell count. This suggests simultaneous expression by cells of both B and T characteristics, named by us as " receptor overlap " (Lin and Hsu, 1976; Habeshaw and Stuart, 1975; Murphy, 1975) .
The receptors expressed at different stages of B-cell differentiation in the mouse have been well documented (Gelfand et al., 1974; Metcalf et al., 1975; Ramasamy, Munro and Milstein, 1974; Sidman and Unanue, 1975a, b) . These showed failure of surface Ig to " cap " (aggregate at one pole of the cell) in the most immature stages. As maturation proceeds, the cells " cap " surface Jg and express first Fc and then both Fc and C3 receptors. The plasma cells, or mature secretory B cells, have inconsistent surface markers, but contain intracytoplasmic Ig (Corte et al., 1976) . We and others have found identical variations in the pattern of surface Ig, Fe and C3 receptors in human material such as normal peripheral blood (Habeshaw and Young, 1975) , tonsil (Siegel, Grieco and Gupta, 1974) , and in lymphomas (Brouet et al., 1975; Dorfman, 1975; Jaffe et al., 1975; Stuart and Habeshaw, 1976; Habeshaw and Stuart, 1975; Moscatelli, Bricarelli and Quartino, 1976) . It therefore seems likely that the sequence of phenotype change seen in mature mouse B-lymphoid populations also occurs in man. If this were true, the expression of surface Ig, Fc and C3 receptors may be a means of assessing cellular differentiation in human B-cell neoplasms. In this paper we propose a scheme of B-cell differentiation in human non-Hodgkin lymphoma based on the experimental and natural observations previously cited.
Tumours in which the B cells express an undifferentiated receptor profile should appear immature histologically and behave aggressively clinically. The opposite should apply to those tumours assessed as well differentiated by surface markers. In this paper we test this hypothesis in 25 tumours of B-cell or receptor-silent type.
MATERIALS AND METHODS
The techniques employed are described in outline only, since details have been reported previously (Habeshaw and Young, 1975; Stuart and Habeshaw, 1976; Dewar et al., 1975) .
Lymph-node cell suspensions.-Cell suspensions in tissue culture medium were prepared from lymph-node biopsy specimens. Habeshaw and Young (1975) . In 6 cases, Fc and C3 receptors were prepared using rabbit anti-ox-RBC IgG (for Fc) and rabbit anti-ox-RBC IgM + human R3 reagent (C3d receptor) (Lachman, Hobart and Aston, 1973) . Controls showed that results obtained with sheep or ox red cells were comparable for Fc and C3d receptors. A heavily sensitized red cell is needed to detect all cells expressing an Fe receptor. Mixed C and Fc receptors were detected using human red cells sensitized with rabbit anti-human-RBC IgG as previously described (Dewar et al., 1974) . Rosette counting is facilitated by the addition of 01 ml of 0.01% solution of acridine orange to the suspended rosettes immediately before examination by fluorescence and phase-contrast microscopy (Brostoff, 1974 Histological and cytological evaluation.
Tissue for histology wNAas taken from the slice of lymph node biopsy next to that from which the cell suspensions were made. Fixation was in 10% formaldehyde in saline. Sections were cut at 2-5 ,tm and stained with H. and E., Gordon and Sweet's reticulin, Giemsa and methyl green-Pyronin stains. The tumours were classified using the Rappaport (1966) and Lukes and Collins (1975) classifications.
Dabs of freshly cut lymph-node surface and smears of the cell suspensions wiere stained with May-Griinwald-Giemsa. As xvell as giving increased cytological detail of the cells, these techniques helped us judge whether the cell population in the tissue sections was equivalent to that in the suspensions. Cytoplasmic immunoglobulin content of the tumours w-as assessed by the P.A.P. immunoglobulin technique of Taylor and Burns (1974) .
RESULTS

Receptor analysis
The results of the receptor analysis in Table I show that 22/29 tumours were predominantly B-cell. Nine of these 22 were classed as " B mixed " since they contained an appreciable number of T cells. Two showed receptor overlap, one was a macrophage tumour and the last a T-cell tumour. surface immunoglobulin (Fig. 1 (1966) The correlation of histology with the B surface phenotype is shown in Table III . Three of the 4 well differentiated lymphocytic lymphomas (Fig. 2) In the nodular lymphomas, all were poorly differentiated lymphocytic histologically (Figs. 3 and 4 with the large non-cleaved tumours.
Large Large lymphocyte and small-cleaved-cell tumours consisted of mature B lymphocytes as judged by receptors. Five of the 6 large non-cleaved tumours (Fig. 5) were either immature or receptor-silent. If the large-cell groups (both cleaved (Fig. 4) and non-cleaved (Fig. 5) ) are taken together, 8/10 show immature receptor profiles or receptor silence. The large-cell groups showed the greatest heterogeneity of receptor expression. In contrast, the small-cell tumours, with 2 exceptions, expressed mature B-lymphocyte characteristics.
DISCUSSION
These studies amply confirm that Bcell tumours are the commonest of the non-Hodgkin lymphomas. However, a variable number of T cells was noted in more mature tumours where frequently neither T nor B cells predominated over the sum of all others present. This mixed pattern was noted especially in the follicular or " nodular " lymphomas. It is not known if this represents contamination of a neoplastic B population by reactive T cells. One may speculate that the physiological cooperation of T and B cells may be echoed in neoplasms and, if so, the concept of " neoplastic " and " reactive ' populations may be functionally irrelevant.
Reservation must be expressed over the small number of T-and macrophagederived tumours observed in this series. Reliance on E rosetting by itself as a method of identifying T cells is possibly insufficient, and current techniques of identifying macrophages ignore the precursor cell. Salmon and Seligmann (1974) proposed a scheme of B-lymphocyte development in lymphoma, based upon the class of secretory or surface-expressed immunoglobulin. The classes of B lymphoma proposed were Bo (B stem cells), B1 (virgin B lymphocyte), B2 (immunoblast), B3 (memory B lymphocyte), B4 (plasmacytoid lymphocyte) and B5 (plasma cell). They suggest that the course of development of lymphoma involves the triggering of a clone of responsive cells by antigen, followed by a second oncogenic stimulus which leads to irreversible proliferation of " committed " B cells. In their classification, the B1 tumours are represented most commonly by CLL and the well differentiated lymphocytic lymphoma group. The B2 tumours are derived by division from B1 cells, and the B2 component is the cell found in poorly differentiated lymphocytic lymphoma, Burkitt's and some histiocytic lymphomas. The B or "memory " cell has no equivalent in the lymphomas, but from it is derived the lymphocytoid plasma cell (B4) This heterogeneity is reflected in the varied clinical behaviour shown by these lymphomas in 2 large retrospective series Durant et al., 1975; Schein et al., 1974) . There is no way of separating the small number of histiocytic lymphomas that do well, even after local treatment, from the many that are rapidly fatal. Identification of distinct sub-groups by receptor studies could therefore be very valuable. It is noteworthy that receptor-overlap is the only receptor class in which there have been no deaths so far; one was a diffuse histiocytic lymphoma, the other diffuse mixed. Both were hard to classify histologically and a search of retrospective material is being undertaken for cases of similar histology.
Neoplastic cells which appear receptorsilent may develop surface immunoglobulin following trypsinization and overnight culture. This treatment is often not possible with large-cell " histiocytic " tumours whose cells in culture show poor viability. Three of our cases were receptor silent at the time of initial biopsy, and 2 became so as their disease progressed. All are dead within 2 years. This pattern of receptor silence must be distinguished from that seen in some patients with diffuse, well differentiated lymphocytic lymphoma and chronic lymphatic leukaemia, whose small round morphologically mature lymphocytes, in both blood and lymph nodes, fail to express surface Ig, C3 and Fc receptors. These are possibly "null" cells. We have encountered one such case, which after trypsinization and overnight culture, expressed non-capping surface fluorescence (Table III) . In 2 similar cases, seen too recently to be included in this series, the cells remained receptor-silent after trypsinization and overnight culture.
Correlation of receptors with clinical survival is not possible with any certainty in this small series, due to the short period of follow-up in some cases. Nevertheless, 10/14 patients with " mature " receptors are still alive (one died of a myocardial infarct) compared with 5/11 whose receptors were " immature ".
